Epizyme

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Epizyme and buy or sell other stocks, options, and ETFs commission-free!

About EPZM

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future. 

CEO
Grant C. Bogle, MBA
CEOGrant C. Bogle, MBA
Employees
250
Employees250
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
250
Employees250

EPZM Key Statistics

Market cap
247.50M
Market cap247.50M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.24M
Average volume4.24M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.80
52 Week high$5.80
52 Week low
$0.411
52 Week low$0.411

EPZM Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.